Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Regulatory News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

Share Price is delayed by 15 minutes
Get Live Data
1,460.00    44.00 (3.11%)
Bid:
1,453.00
Ask:
1,454.00
Spread: 1.00 (0.069%)
Market Cap: £3.10b
HIK Live PriceLast checked at - London Stock Exchange

Intraday Hikma Pharmaceuticals Share Chart

Blocklisting Interim Review

6 Oct 2014 15:58

RNS Number : 5739T
Hikma Pharmaceuticals Plc
06 October 2014
Β 

ο»Ώ

Β 

Block Listing Six Monthly Return

Β 

Information provided on this form must be typed or printed electronically and provided to an RIS.

Β 

Date: 6 October 2014

Β 

Name of applicant:

Hikma Pharmaceuticals PLC

Name of scheme:

Hikma Pharmaceuticals PLC 2004 Stock Option Plan ("SOP")

&

Hikma Pharmaceuticals PLC 2005 Long-Term Incentive Plan ("LTIP")

&

Hikma Pharmaceuticals PLC 2009 Management Incentive Plan ("MIP")

Period of return

From:

1 April 2014

To:

30 September 2014

Balance of unallotted securities under scheme(s) from previous return:

SOP: 967,900 ordinary shares of 10 pence

LTIP: 400,050 ordinary shares of 10 pence

MIP: 378,360 ordinary shares of 10 pence

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

SOP: 0 ordinary shares of 10 pence

LTIP: 0 ordinary shares of 10 pence

MIP: 0 ordinary shares of 10 pence

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

SOP: 38,200 ordinary shares of 10 pence

LTIP: 0 ordinary shares of 10 pence

MIP: 356,752 ordinary shares of 10 pence

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

SOP: 929,700 ordinary shares of 10 pence

LTIP: 400,050 ordinary shares of 10 pence

MIP: 21,608 ordinary shares of 10 pence

Β 

Name of contact:

Peter Speirs

Telephone number of contact:

0207 399 2772

Β 

Β 

Β 

Β 

Β 

Stock Option Plan ("SOP")

Date

Block Listing

Shares Issued

Balance (Headroom)

Notes

01/04/2014

-

-

967,900

Blocklisting return 01/04/2014

10/04/2014

0

8,500

959,400

25/04/2014

0

2,500

956,900

23/05/2014

0

1,000

955,900

12/06/2014

0

2,500

953,400

12/06/2014

0

1,700

951,700

21/08/2014

0

6,000

945,700

21/08/2014

0

7,500

938,200

12/09/2014

0

8,500

929,700

Blocklisting return 30/09/2014

Β 

Long Term Incentive Plan ("LTIP")

Date

Block Listing

Shares Issued

Balance (Headroom)

Notes

01/04/2014

-

-

400,050

Blocklisting return 01/04/2014

30/09/2014

-

-

400,050

Blocklisting return 01/10/2014

Β 

Β 

Management Incentive Plan ("MIP")

Date

Block Listing

Shares Issued

Balance (Headroom)

Notes

01/04/2014

-

-

378,360

Blocklisting return 01/04/14

18/05/2014

0

261,480

116,880

12/06/2014

0

11,619

105,261

13/06/2014

0

77,487

27,774

30/06/2014

0

741

27,033

07/08/2014

0

2,856

24,177

22/08/2014

0

794

23,383

04/09/2014

0

300

23,083

12/09/2014

0

1,475

21,608

Β Blocklisting return 01/10/14

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
BLRKMMGGDVVGDZM
Date   Source Headline
7th Apr 20164:08 pmRNSDirector/PDMR Shareholding
7th Apr 201611:41 amRNSAnnual Information Update
7th Apr 201610:54 amRNSAnnual Financial Report
6th Apr 20164:11 pmRNSBlocklisting Interim Review
5th Apr 20164:13 pmRNSDirector/PDMR Shareholding
31st Mar 20165:37 pmRNSDirector/PDMR Shareholding
29th Mar 20169:36 amRNSDirector/PDMR Shareholding
21st Mar 20162:54 pmRNSDirector/PDMR Shareholding
17th Mar 20163:25 pmRNSDirector/PDMR Shareholding
16th Mar 20167:00 amRNSFinal Results
3rd Mar 20169:25 amRNSNotice of Results
29th Feb 20162:01 pmRNSHolding(s) in Company
29th Feb 20161:59 pmRNSHolding(s) in Company
29th Feb 20161:47 pmRNSTotal Voting Rights
29th Feb 20161:46 pmRNSRoxane Acquisition Close
22nd Feb 20169:52 amRNSDirectorate Change
19th Feb 201612:55 pmRNSEGM Statement
11th Feb 201612:43 pmRNSHolding(s) in Company
11th Feb 201612:19 pmRNSCirc re. Roxane Acquisition
10th Feb 201610:38 amRNSHikma Analyst and Investor Call
10th Feb 20167:00 amRNSCirc re. Roxane Acquisition
22nd Jan 20162:04 pmRNSCirc re. Roxane Acquisition and EGM
7th Jan 201611:08 amRNSTotal Voting Rights
24th Dec 20157:52 amRNSShareholders' Agreement and Board Appointment
17th Dec 20159:38 amRNSTotal Voting Rights
3rd Dec 20159:30 amRNSDirector/PDMR Shareholding
25th Nov 20158:45 amRNSHikma announces sale of Ben Venue manufacturing
24th Nov 20157:00 amRNSHolding(s) in Company
18th Nov 20157:00 amRNSResolution to FDA Warning Letter
16th Nov 20153:04 pmRNSHolding(s) in Company
11th Nov 20154:16 pmRNSHolding(s) in Company
10th Nov 20152:43 pmRNSHolding(s) in Company
2nd Nov 20157:00 amRNSTrading Statement
22nd Oct 20157:00 amRNSBlock Listing of Share
19th Oct 201511:11 amRNSHolding(s) in Company
12th Oct 201510:25 amRNSBlocklisting Interim Review
8th Oct 20154:10 pmRNSTotal Voting Rights
18th Sep 20152:40 pmRNSAudit Tender
16th Sep 20154:08 pmRNSTotal Voting Rights
11th Sep 20153:47 pmRNSDirector/PDMR Shareholding
8th Sep 20157:00 amRNSHikma agrees to acquire EIMC United Pharmaceutical
27th Aug 20154:02 pmRNSDirector/PDMR Shareholding
27th Aug 20153:03 pmRNSDirector/PDMR Shareholding
19th Aug 20156:28 pmRNSDirector/PDMR Shareholding
19th Aug 20157:00 amRNSInterim Results
28th Jul 20157:00 amRNSAcquisition
14th Jul 201511:12 amRNSTotal Voting Rights
18th May 201510:30 amRNSHikma Founder Samih Darwazah passes away
18th May 201510:00 amRNSDirector/PDMR Shareholding
15th May 20151:25 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.